The advertisement promotes MAVYRET as a treatment for Hepatitis C, highlighting its unique 8-week duration and safety warnings regarding potential Hepatitis B virus reactivation in coinfected patients.
Creative Information
| CID: | 9d892cc8-7d14-4c50-8794-6904bf5ee06e |
| CRID: | 82_5586-947061 |
| Domain: | mavyret.com |
| Seat: | PP |
| Size: | 160x600 |
| Bid: | $1.09 |
| Timestamp: | 11/10/2025, 6:37:07 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/10/2025, 6:55:36 PM | 7.09s | |
| adomain_analysis | success | 11/10/2025, 8:32:22 PM | 3.74s | |
| adomain_capture | success | 11/10/2025, 8:32:18 PM | 0.28s | |
| ad_render | success | 11/10/2025, 6:55:28 PM | 24.42s | |
| brand_mapping | success | 11/10/2025, 6:37:07 PM | 0.10s | |
Analysis Results
Ad Format: banner
Brands: Mavyret
Sensitive:Misleading Health ClaimsUnverified Medical TreatmentsPharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 160x600 | ||||||||||||||||||||||
| Data Transferred: | 1689.71 KB | ||||||||||||||||||||||
| Render Time: | 9.09 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1689.84 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


